LEVIA : A New Injectable Parasiticidal Veterinary Formulation of Levamisole HCl and Ivermectin Solution.
OwnerOthman Abdulrahim Radi Alhanbaliinventor
Life of this patent
Estimating the term…
Abstract
This invention (LEVIA) is a new preservative free veterinary formulation, composed of 7.5% Levamisole HCl and 1% Ivermectin. This unique combination provides a very effective anthelmintic effect against, animal pests and endoparasites. In addition, this formula may be used for combating, killing and/or controlling: 1—Adult and immature gastro intestinal round worms; 2—Lung worms, eye worms and warble fly larvae; 3—Helps in treatment of Sarcoptes and Psoroptes Scabies (mange mites) and control of Sucking Lice. This invention provides an improved method for the treatment of helminthiasis in mammals, particularly in: bovines, caprines, equines, ovines, canines and felines.
Claims13
LEVIA is a new colorless, preservative free sterile veterinarian solution, adapted to be subcutaneously injected into animals, this formulation comprises of:
- a. an effective amount of 7.5% Levamisole HCl;
- b. an effective amount of at least 1% Ivermectin;
- c. a pharmaceutically acceptable system of Propylene glycol C3H802 (mwt 76.1) as a solvent wherein the system provides for acceptable storage stability for both the Levamisole HCl and the Ivermectin and wherein the system provides for a viscosity which is suitable for injection;
- and wherein the system contains 7% water for injection.
This subcutaneous solution is pyrogen free and sterile.
Dependencies are inferred from the claim text.